FDA Drug Application (202236) for DYMISTA by MEDA PHARMS

Back to FDA Applications sponsored by MEDA PHARMS

Application Number202236
Product Number001
FormSPRAY, METERED;NASAL
DosageEQ 0.125MG BASE/SPRAY;0.05MG/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYMISTA
Active IngredientAZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE



Back to FDA Applications sponsored by MEDA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.